ANTX
AN2 Therapeutics, Inc. · Healthcare
Adjuvant Global Health Technology Fund, L.P. bought $2.5M of AN2 Therapeutics, Inc.
10% owner
Bought$2,499,990
$15.00Price
166,666Shares
+7%Stake
What ANTX did for a copier
- $1,000 copied at Fri, Apr 1 open, $15.38
- $1,198
- S&P 500, same days
- −11.7%
Measured over 30 trading days, to the May 16 close.
Adjuvant Global Health Technology Fund, L.P.'s record
No other buys on record. A record shows here once 3 buys have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, Mar 29. Filed Thu, Mar 31, 4:15 PM ET, after the close. Returns use the Apr 1 open and the May 16 close. Not investment advice.